Brief: Mauna Kea Technologies Starts Enrollment In Peripheral Lung Cancer Multi-Center Clinical Trial
Feb 22 (Reuters) - Mauna Kea Technologies SAS MKEA.PA :
* ANNOUNCES START OF ENROLLMENT IN PERIPHERAL LUNG CANCER
MULTI-CENTER CLINICAL TRIAL
* THIS STUDY WILL INCLUDE UP TO 75 PATIENTS WITH PERIPHERAL
LUNG
NODULES IN AT LEAST 3 U.S. CENTERS
Source text for Eikon: ID:nBw6Nln3na
Further company coverage: MKEA.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on Mauna Kea Technologies SA
See all newsBrief: Mauna Kea Technologies Confirms Trajectory Toward Profitability By Year-End 2027
Brief: Mauna Kea Technologies Announces Results Of Its Combined General Meeting
French and Benelux stocks-Factors to watch 21 Nov
Brief: Mauna Kea Technologies Receives NMPA Regulatory Approval In China For Its Next-Generation Cellvizio Platform
Europe Research Roundup: Craneware, Croda, Genus